Economic evaluation in the development of medicines: by Michael Drummond, George Teeling Smith and Nicholas Wells. Office of Health Economics, London, 1988. 36 pp. No price given

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Social Science & Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Business, Economics

• Identifiers
  DOI 10.1016/0277-9536(89)90244-X
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Pharmacogenomics in Precision Medicine: From a Perspective of Ethnic Differences

  2020cites this paper
• A study to evaluate prescribing pattern and cost minimization analysis of antihistamines among patients of allergy

  2016cites this paper
• SCOPE OF PHARMACOECONOMICS To Pharmaceutical manufacturers

  2015cites this paper
• Cost Minimization Analysis of Antibacterial Therapy In A Developing Country

  2013cites this paper
• Mental Health in the 1990 s From custody to care ?

  2012cites this paper
• The Changing Healthcare Environment

  2012influential citation
• ( DhE innovative Chemical ^ xteqsions 9 the economic basis of pharmaceutical progress

  2012cites this paper
• Economic Evaluation pf Antibacterial Usage in Ear, Nose and Throat Infections in a Nigerian Teaching Hospital

  2011cites this paper
• Pharmacoeconomics: Principles, Methods, and applications

  2011cites this paper
• KAUNAS UNIVERSITY OF MEDICINE

  2005cites this paper
• Approche économique de la prise en charge des coliques néphrétiques de l'adulte en urgence

  1999cites this paper
• Ökonomische Evaluationen im Rahmen klinischer Studien

  1998cites this paper
• European School of Oncology Advisory report to the Commission of the European Communities for the "Europe Against Cancer Programme" cost-effectiveness in cancer care.

  1995cites this paper
• Cost management in community-acquired lower respiratory tract infection.

  1995cites this paper
• Measuring the unmeasurable: the role and importance of quality of life measurement in economic evaluations of sleep disorder treatment

  1995cites this paper
• Drug Utilisation Studies as Tools in Health Economics

  1994cites this paper
• Economic Outcomes of Colfosceril Palmitate Rescue Therapy in Infants Weighing 1250g or More with Respiratory Distress Syndrome

  1994cites this paper
• The drug formulary approval process in select Canadian hospitals

  1994cites this paper
• Quality of life 2

  1993cites this paper
• The demand for food safety: Market imperfections and the role of government

  1993cites this paper
• Health services research in oncology.

  1993cites this paper
• Implications of basing health-care resource allocations on cost-utility analysis in the presence of externalities.

  1992cites this paper
• The economic evaluation of cancer treatments and programmes.

  1991cites this paper
• Economic Analyses in Hypertension: Applications for Healthcare Providers

  1991cites this paper
• Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues

  1991cites this paper
• A study of patient outcomes in an acute hospital.

  1991cites this paper
• The cost-benefit approach to pricing new medicines: doxazosin versus beta-blocker treatment in Sweden.

  1990cites this paper
• Estimating Costs in the Economic Evaluation of Medical Technologies

  1990cites this paper
• 12 The economics of cholesterol lowering

  1990cites this paper
• Clinical Economics: A Guide to the Economic Analysis of Clinical Practices

  1989cites this paper